Search

everythinglearnresearchcommunity

for

Search:↓

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.